[D-Ala2]-GIP (human)

[D-Ala2]-GIP (human)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TP2019-1mg 1 mg

7 - 10 business days*

1,592.00€
 
Description: Highly potent GIP receptor agonist (EC50 = 630 ± 119 pM). Displays equivalent cAMP... more
Product information "[D-Ala2]-GIP (human)"
Description: Highly potent GIP receptor agonist (EC50 = 630 ± 119 pM). Displays equivalent cAMP stimulating properties and improved resistance to enzymatic degradation compared to native GIP in cells expressing wild type GIP receptor. Improves glucose tolerance, insulin release and cognitive function in various animal models of obesity and diabetes. Displays neuroprotective effects in an MPTP model of PD. References: Hinke et al (2002) Dipeptidyl peptidase IV-resistant [D-Ala2]glucose-dependent Insotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats. Diabetes. 51 652 PMID:
Supplier: TargetMol
Supplier-Nr: TP2019

Properties

Conjugate: No
MW: 4983.58 D
Formula: C226H338N60O66S

Database Information

CAS : 444073-04-5| Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "[D-Ala2]-GIP (human)"
Write a review
or to review a product.
Viewed